Ingredient record · Local anaesthetic
Lignocaine: bans, restrictions and failed batches in India
Last checked 20 September 2026. Sources: CDSCO banned-drugs notifications and monthly NSQ alerts, Jan 2019 to Jul 2026
24 entries containing Lignocaine are on India's banned-drugs list, and 14 are banned today. 13 batches of medicines containing Lignocaine failed a government lab test between March 2019 and June 2026, from 8 manufacturers. A failed batch concerns that batch only, not the medicine or every brand.
14
Banned combinations in force
10
Other listed orders (stayed, restricted, quashed)
13
Batches failed a lab test
Jun 2026
Latest lab alert
On the banned-drugs list
Lignocaine on its own is not on CDSCO's banned list. The entries below are specific combinations that contain it. Status follows CDSCO's own notes on each entry.
| Drug / combination | Action | Notification | Date | Order | Status note |
|---|---|---|---|---|---|
| Paracetamol + LignocaineFixed-dose combination · painkillers | Banned | S.O. 3079(E) | 11 June 2026 | 16 FDCs · Jun 2026 | Prohibited under s.26A with immediate effect, 11.06.2026 (CDSCO list published 21.07.2026). |
| Menthol + Lignocaine HCl + Aloe Vera Gel + Clotrimazole + DiphenhydramineFixed-dose combination · skin | Banned | S.O. 3325(E) | 2 August 2024 | 156 FDCs · Aug 2024 | Prohibited under s.26A; notifications dated 02.08.2024, gazetted 21-22 Aug 2024. |
| Beclomethasone Dipropionate + Neomycin Sulphate + Clotrimazole + Lignocaine HClFixed-dose combination · skin | Banned | S.O. 3355(E) | 2 August 2024 | 156 FDCs · Aug 2024 | Prohibited under s.26A; notifications dated 02.08.2024, gazetted 21-22 Aug 2024. |
| Ofloxacin + Beclomethasone Dipropionate + Lignocaine HClFixed-dose combination · skin | Banned | S.O. 3379(E) | 2 August 2024 | 156 FDCs · Aug 2024 | Prohibited under s.26A; notifications dated 02.08.2024, gazetted 21-22 Aug 2024. |
| Ofloxacin + Diclofenac + LignocaineFixed-dose combination · painkillers | Banned | S.O. 257(E) | 11 January 2019 | Other orders | One of 80 FDCs prohibited vide S.O. 180(E)-259(E) dated 11.01.2019 (CDSCO letter 22.01.2019). In force per CDSCO list as on 22.11.2021. |
| Lignocaine + Clotrimazole + Ofloxacin + BeclomethasoneFixed-dose combination · skin | Banned | S.O. 4442(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Chloramphenicol + Beclomethasone + Clotrimazole + LignocaineFixed-dose combination · skin | Banned | S.O. 4488(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Chloramphenicol + Ofloxacin + Lignocaine + Glycerine and Propylene GlycolFixed-dose combination · skin | Banned | S.O. 4489(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Chloramphenicol + Lignocaine + Betamethasone + Clotrimazole + Ofloxacin + AntipyrineFixed-dose combination · skin | Banned | S.O. 4490(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Ofloxacin + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Banned | S.O. 4491(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Gentamicin Sulphate + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Banned | S.O. 4492(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Clotrimazole + Beclomethasone + Ofloxacin + LignocaineFixed-dose combination · skin | Banned | S.O. 4493(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Beclomethasone + Clotrimazole + Chloramphenicol + Gentamicin + Lignocaine Ear DropsFixed-dose combination · skin | Banned | S.O. 4494(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Clotrimazole + Beclomethasone + Lignocaine + Ofloxacin + Acetic Acid + Sodium Methyl Paraben + Propyl ParabenFixed-dose combination · skin | Banned | S.O. 4701(E) | 7 September 2018 | 328 FDCs · Sep 2018 | In force per CDSCO list as on 22.11.2021 |
| Benzoxoniumchloride + LidocaineFixed-dose combination · painkillers | Quashed | S.O. 735(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Lignocaine + Clotrimazole + Ofloxacin + BeclomethasoneFixed-dose combination · skin | Quashed | S.O. 773(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Chloramphenicol + Beclomethasone + Clomitrimazole + LignocaineFixed-dose combination · skin | Quashed | S.O. 825(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Clotrimazole + Ofloxaxin + Lignocaine + Glycerine and Propylene GlycolFixed-dose combination · skin | Quashed | S.O. 826(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Chloramphenicol + Lignocaine + Betamethasone + Clotrimazole + Ofloxacin + AntipyrineFixed-dose combination · skin | Quashed | S.O. 827(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Ofloxacin + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Quashed | S.O. 828(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Gentamicin Sulphate + Clotrimazole + Betamethasone + LignocaineFixed-dose combination · skin | Quashed | S.O. 829(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Clotrimazole + Beclomethasone + Ofloxacin + LignocaineFixed-dose combination · skin | Quashed | S.O. 830(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Becloemthasone + Clotrimazole + Chloramphenicol + Gentamicin + Lignocaine Ear DropsFixed-dose combination · antibiotics | Quashed | S.O. 831(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
| Clotrimazole + Beclomethasone + Lignocaine + Ofloxacin + Acetic Acid + Sodium Methyl Paraben + Propyl ParabenFixed-dose combination · skin | Quashed | S.O. 1048(E) | 10 March 2016 | 344 FDCs · Mar 2016 | Quashed by Delhi HC 1 Dec 2016; see 2018 re-ban |
Products that failed lab tests
Product names as printed by the testing labs, grouped. Open a product to see every batch number.
| Product | Batches | Makers | Latest |
|---|---|---|---|
| Lignocaine Adrenaline | 4 | 3 | Jan 2026 |
| Lignocaine Hydrochloride W/v | 2 | 1 | Feb 2025 |
| Lignocaine Hydrochloride | 2 | 2 | Dec 2023 |
| Phenazone Lidocaine Hydrochloride | 1 | 1 | Jun 2026 |
| Choline Salicylate Lignocaine Hcl Benzalkonium Chloride | 1 | 1 | Mar 2026 |
| Lidocaine Hydrochloride Gabapentin | 1 | 1 | Apr 2025 |
| Progaba | 1 | 1 | Apr 2025 |
| Ligno | 1 | 1 | Mar 2019 |
Most recent failed batches
| Product | Batch | Manufacturer | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|---|
| Phenazone & Lidocaine Hydrochloride Ear Drops -5ml | AOT01ACBMfg 2026-01 · Exp 2027-12 | Pure & Cure Healthcare Pvt. LtdUttarakhand | ContentOther | DTL, Chennai-25State lab | Jun 2026 |
| Choline Salicylate, Lignocaine HCL, Benzalkonium Chloride GEL | AXO-267Mfg 2025-10 · Exp 2027-09 | Axelus Pharma Private Limited | The sample doe not conform to the Manufacturer's specification with respect to the Assay of Choline Salicylate.Assay | CDTL, MumbaiCDSCO lab | Mar 2026 |
| Lignocaine and Adrenaline Injection IP | HILR25002Mfg 2025-01 · Exp 2026-12 | Health Biotech LtdHimachal Pradesh | The sample does not conform to IP with respect to test for Particulate matter,Assay of Adrenaline Bitartrate eq. to Adrenaline and Description.Assay | CDL, KolkataCDSCO lab | Jan 2026 |
| Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | PSWAB66Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to Label claim with respect to the content of GabapentinLabelling | DTL MaduraiState lab | Apr 2025 |
| Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | PWBBO7Mfg 2024-06 · Exp 2025-11 | Pure & Cure Healthcare Pvt. LtdUttarakhand | Sample does not conform to lebel claim with respect to the content of GabapentinOther | DTL MaduraiState lab | Apr 2025 |
| Lignocaine Hydrochloride Gel IP 5 % w/v (30 g) | G407Mfg 2024-09 · Exp 2026-08 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | "pH"pH | CDTL MumbaiCDSCO lab | Feb 2025 |
| Lignocaine Hydrochloride Gel IP 5% w/v (30 g) | G406Mfg 2024-09 · Exp 2026-08 | Gnosis Pharmaceuticals Pvt. LtdHimachal Pradesh | pHpH | CDL KolkataCDSCO lab | Dec 2024 |
| LIGNOCAINE HYDROCHLORIDE INJECTION I.P. (A-CAINE) | HILA23013 CMfg 2023-08 · Exp 2025-07 | Health Biotech LtdHimachal Pradesh | Assay of Lignocaine HydrochlorideAssay | CDL KolkataCDSCO lab | Dec 2023 |
| Lignocaine Hydrochloride Gel IP (LIGNOMARK JELLY) | E1C060Mfg 2021-03 · Exp 2023-02 | Smayan Healthcare Pvt. LtdHimachal Pradesh | AssayAssay | RDTL ChandigarhCDSCO lab | Mar 2022 |
| Lignocaine and Adrenaline Injection IP (A- CAINE ADR INJECTION) | HILR2006FMfg 2020-11 · Exp 2022-10 | Health Biotech LtdHimachal Pradesh | Assay of AdrenalineAssay | RDTL ChandigarhState lab | Nov 2021 |
| Lignocaine With Adrenaline Injection IP | LAN-113AMfg 2019-07 · Exp 2020-12 | Pushkar Pharma | Assay of Adrenaline BitartrateAssay | RDTL ChandigarhCDSCO lab | Apr 2020 |
| Lignocaine and Adrenaline Injection IP | V-7079Mfg 2017-11 · Exp 2019-10 | Alpa Laboratories LtdMadhya Pradesh | Test for AssayAssay | RDTL ChandigarhState lab | Jun 2019 |
| LIGNO 2% (Lignocaine HCl Injection I.P.) | RLE27Mfg 2018-02 · Exp 2020-01 | Rainbow Laboratories | Description, pH and Particulate MatterDescription | CDL KolkataCDSCO lab | Mar 2019 |
Holding a strip or bottle? The batch number is printed after "B. No." Check it against every alert. If it matches, return it to the pharmacy. What the labels mean: status guide.